GILD GILEAD SCIENCES, INC.
Research report · from SEC EDGAR · close 2026-07-13
$131.40 +1.2%
$163.14B mkt cap
executive summary
GILEAD SCIENCES, INC. (GILD) is a $163.14B company. Revenue is $29.44B (+2.4% y/y) at a 29% net margin. It is profitable. Our health score is B (80/100). No major red flags on file. Smart money is buying (2 Congress). It funds itself; low dilution risk.
Revenue (FY)
$29.44B
+2.4% y/y
✓ No major red flags from our filing-based checks.
who's buying
Insider buys / sells
0 / 10
Cash & ST investments
$6.38B
Operating cash flow
$10.02B
Dilution shelf
active shelf
Assembled from SEC EDGAR (XBRL, Form 4, 13F, filings), STOCK Act disclosures, and end-of-day prices — every figure is real and sourced; nothing is fabricated or predicted. Filings lag 40–90 days. Educational, not investment advice. Generated 2026-07-13 by stocktools.ai.